SUBSCRIBE
SUBSCRIBE

MicroRNA (miRNA) Market Size up to 2030 - Quantitative Research by QYResearch Medical

November 17, 2022 | 
8 min read

The global MicoRNA (miRNA) Market was valued at USD 190.6 Million in 2020 and is expected to reach USD 458.0 Million by 2030, at a CAGR of 11.6%.

The global MicoRNA (miRNA) Market was valued at USD 190.6 Million in 2020 and is expected to reach USD 458.0 Million by 2030, at a CAGR of 11.6%. MicroRNA (miRNA) is a category of miniature noncoding RNA of ∼22nt in length which is responsible for RNA silencing and post-transcriptional requirement of gene expression and they target multiple cancer cells at one point. They work via base-pairing with complementary sequences within mRNA molecules. Lately, they have been examined as innovative classes of therapeutic agents for healing a broad range of syndromes including cancers and infections. Key recent developments in the field of miRNA market include development of new product tools. For instance, in 2020, the Nano String Technologies Inc. launched the GeoMx™ Digital Spatial Profiler facilitating highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.

The market is moderately consolidated due to the existence of a large number of pharmaceutical giants as well as emerging players that have great knowledge in the genomics & biotechnology market. These players are involved in joint ventures to develop advanced products. These players are focusing on the development of advanced technologies to improve the quantification, detection, and functional analysis workflows for research. For instance, in September 2018, Twentyeight-Seven Therapeutics, a biotechnology company accepted USD 65 million from a joint venture of MPM Capital and Novartis Venture Fund for the advancement of 28-7’s lead program to target microRNA modulating proteins for the treatment of cancer.

Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118307

Recent improvements in MicroRNA applications like potential biomarkers in advanced diagnostics have accelerated new product development and demand for miRNA has increased exponentially. Usage of bioinformatics and technologically advanced systems (such as NGS) are set to drive the market growth. One of the major factors contributing to market growth is the establishment of huge amount of public and private funding. Growth in this market is fuelled by factors such as the advantages of miRNA sequencing over other technologies, increase in launching of products for genomics, and the exponentially decreasing cost of sequencing. Complex nature of MicroRNAs and their instability increase the inconveniency in their development. The problems associated to quantification and the improvement of MicroRNA research tools such as microarrays are assumed to obstruct the market growth. Another major restraint is the limited life science research infrastructure in emerging markets.

Related Reports:

Salient Trends of the Global MicroRNA (miRNA) Market:

  • The Merger and Acquisition (M&A) deal between STA Pharmaceutical Co., Ltd. and Regulus Therapeutics, took effect on February, 2018 to provide STA Pharmaceutical’s manufacturing facility to the company.
  • The Partnership deal between Thermo Fisher Scientific and Illumina Inc. in January 2018 enabled Illumina to sell Ion AmpliSeq technology which is highly effective in capturing DNA and RNA from small samples for applications in research and can help out the customers.
  • In August 2017, with an approval of Mirna’s stockholders, Synlogic Inc. and Mirna Therapeutics Inc. merged to operate as Synlogic Inc. to focus on improving Synlogic’s platform for development of Synthetic BioticTM
  • In March 2017, Takara Bio acquired WaferGen at $35.9 million to magnify Takara Bio’s international commercials contributions in transcriptomics and generate new market prospects in several zones of genomics.
  • Launch of new products for microRNA analysis boosts up the market growth during coming years. For instance, in March 2017, NanoString Technologies, Inc. launched nCounter® PlexSet™ reagents as an alternative to qPCR at the Association of Biomolecular Resource Facilities (ABRF) conference in San Diego, California which allow nCounter digital gene expression analysis that is more proficient and affordable than other projects.
  • Technological improvements and continuous rise in the number of research studies on microRNA being published is anticipated to create prospects for the growth of global miRNA For instance, in January 12 2017, Damon Runyon Cancer Research Foundation (U.S.) granted fellowship to 16 scientists for supporting translational cancer research.
  • In August 2016, Merger and Acquisition (M&A) deal between PerkinElmer and Bioo Scientific took effect which provided consumables solutions for life science research.
  • For instance, in May 2015, Researchers from Agency for Science, Technology, and Research (A*STAR) Bioprocessing Technology Institute and the National University of Singapore constructed an algorithm and miRNA detection technology for detecting cancer without using any instruments. The test encompasses identifying miRNAs from a little amount of blood, which brands it as an outstanding biomarker of the chronic disease.
  • Asia Pacific region has the highest prevalence rate for chronic diseases such as Cancer and others. Asia Pacific region is expected to grow at a CAGR of 12.6% by year 2030.

Key Coverage of the Report:

  • Region and country-wise assessment from the period 2020-2030. For the study, 2016-2017 has been utilized as historical data, 2018 as the base year, and 2020-2030, has been derived as forecasts.
  • Regional Competitors clinical pipeline analysis
  • Demand and Supply GAP Analysis
  • Market share analysis of the key industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments

Companies considered and profiled in this market study:

The Global miRNA Market study postulates constructive intuition globally which includes the companies who are the key players in Global miRNA Market, such as Agilent Technologies, Alnylam Pharmaceuticals, Bio-Rad Laboratories, GeneCopoeia, Inc., Illumina, Inc., Merck KGaA, Miltenyi Biotec, NanoString Technologies, Inc., New England Biolabs, Inc., QIAGEN (Exiqon), Rosetta Genomics, Thermo Fischer Scientific Inc.

Market-O-Nomics:

  • Kits, Reagents and Consumables is the leading product type expected to grow during the forecast period, owing to its huge development and even many companies have invested a lot behind the development.
  • Biomarkers segment type is the fastest growing with a CAGR of 13.6% for its immense global awareness and acceptance across the regions.
  • The market for cancer segment dominated the miRNA market as RNAs serve ideal candidates in the form of non-invasive biomarkers.
  • Academic & government research organizations segment type is a significant revenue sponsor as huge chunk of microRNA research is performed with a CAGR of 11.6%.
  • Functional studies services are the leading revenue contributor in 2018. Higher adoption of functional studies to investigate the role of different miRNAs in various diseases contributes to the larger share in revenue compared to other services.
  • North America has the largest market size and anticipated to remain same throughout the forecast period at a CAGR of 11.4% because of strong methodological and funding for research in the fields of genomics and RNA.

Segments covered in the report:

For the purpose of the study, this report segments the Global MicroRNA (miRNA) Market on the basis of product type, research tools and services (Tools and Services), application, end user and the regional outlook at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2030.

Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118307

MicroRNA (miRNA) Market Report Scope

Segments covered By Product Type, Research Tools and Services, Application, End Use, Regional Outlook

By Product Type

Instruments

Kits, Reagents & Consumables

Isolation & Purification

Quantification & Detection

Functional Analysis

Others

By Research Tools and Services

Tools

qRT-PCR

Biomarkers

Next Gen Sequencing (NGS)

Microarray Analysis Tools

Functional Analysis Tools

Extraction Tools

Others

Services

miRNA cDNA Synthesis

Quantification Services

Microarray Services

Sequencing Services

Functional Studies Services

Others

By Application

Cancer

Infectious Diseases

Immunological Disorder

Cardiovascular Disease

Neurological Disease

Others

By End Use

Academic & Research Institutes

Biopharmaceutical Companies

CRO

Diagnostic Centres

Regional scope

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118307/1500

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:

URL - http://www.qyresearchmedical.com/

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Precedence Research